Skip to main content
Joshua Rosenblatt, MD, Internal Medicine, New York, NY

JoshuaRosenblattMD

Internal Medicine New York, NY

HIV/AIDS Medicine, Infectious Disease

Infectious Diseases at NewYork Presbyterian/Weill Cornell Medical Center

Overview of Dr. Rosenblatt

Dr. Joshua Rosenblatt is an internist in New York, NY and is affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. He received his medical degree from Tufts University School of Medicine and has been in practice 2 years. He also speaks multiple languages, including French. He specializes in infectious disease and is experienced in infectious disease, primary care, and internal medicine.

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Infectious Disease, 2019 - 2021
  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2016 - 2019
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 2016

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2020 - 2026
  • PA State Medical License
    PA State Medical License 2016 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Richard C Gozon Compassion in Medicine Award Office of Graduate Medical Education at Thomas Jefferson University and affiliated hospitals, 2018-2019
  • Resident of the Month Thomas Jefferson University Hospital Division of Hospital Medicine, 2018

Publications & Presentations

PubMed

Abstracts/Posters

  • Cavitary pneumonia in a patient with levamisole-induced vasculitis
    Rosenblatt J & Amer K, ACP Southeastern Regional Meeting, Philadelphia, PA, 11/3/2018
  • Pennsylvania Drug Monitoring Program - Evaluation of Barriers to Registration among House Staff
    Rosenblatt J, Cao C & Zavodnick J, Thomas Jefferson University Hospital House Staff Quality and Safety Poster Session, Philadelphia, PA, 6/7/2018

Authored Content

  • Infants cured of 'bubble boy' immune disease with experimental gene therapyApril 2019
  • More screen time linked to higher risk of ADHD in preschool-aged childrenApril 2019
  • Superbug fungus a 'serious global health threat' as over 600 in US are infectedApril 2019
  • Broken heart syndrome: How emotional stress can mimic heart attack symptomsApril 2019
  • Join now to see all

Press Mentions

  • Lenacapavir: a new treatment of resistant HIV-1 infections
    Lenacapavir: a new treatment of resistant HIV-1 infectionsMarch 1st, 2023
  • Updates in pre-exposure prophylaxis for HIV
    Updates in pre-exposure prophylaxis for HIVMarch 1st, 2022

Professional Memberships

Other Languages

  • French